Clinical Trial Update: Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression

View source ↗

Summary

Expanded Access Protocol update for Zulresso (brexanolone) injection to treat postpartum depression in adults; the drug is listed as approved for marketing and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• Zulresso (brexanolone)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Postpartum Depression | Status: APPROVED_FOR_MARKETING